Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Durability and long-term outcomes of biologic therapies in psoriasis
Lluís Rusiñol, Elena Carmona‐Rocha, L. Puig
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 1, pp. 71-82
Closed Access | Times Cited: 11

Showing 11 citing articles:

Understanding the role of immune-mediated inflammatory disease related cytokines interleukin 17 and 23 in pregnancy: a systematic review.
Aniek Plug, Liana Barenbrug, Bart G. J. Moerings, et al.
Journal of Translational Autoimmunity (2025) Vol. 10, pp. 100279-100279
Open Access | Times Cited: 1
Effects of tumor necrosis factor-alpha inhibitors on lipid profiles in patients with psoriasis: a systematic review and meta-analysis
Liang Su, Chunyan Xu, Hong Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Exploring the therapeutic potential of Abelmoschi Corolla in psoriasis: mechanisms of action and inflammatory pathway disruption
Baoquan Qu, Guanglu Li, Ning Zhao, et al.
Phytomedicine (2025) Vol. 138, pp. 156379-156379
Closed Access
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
Laura Mateu Arrom, L. Puig
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 363-379
Closed Access | Times Cited: 3
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies
Giacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 1
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression
Maria-Lorena Mustață, Mihaela Ionescu, Lucrețiu Radu, et al.
Diagnostics (2024) Vol. 14, Iss. 24, pp. 2887-2887
Open Access | Times Cited: 1
Research trends and hotspots in biologics for plaque psoriasis: A bibliometric study from 2004 to 2023
Shan Huang, Xingwu Duan, Yanping Bai
Heliyon (2024) Vol. 10, Iss. 15, pp. e35446-e35446
Open Access
A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice
Martina Burlando, Ilaria Salvi, Aurora Parodi, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 9, pp. 2645-2652
Open Access
Single-Cell Sequencing Combined with Transcriptome Sequencing to Explore the Molecular Mechanisms Related to Psoriasis
E Cailing, Rongying Wang, Zudong Meng, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2197-2213
Open Access
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
Saakshi Khattri, Álvaro González‐Cantero, Burhan Engın, et al.
Advances in Therapy (2024)
Open Access
Page 1

Scroll to top